CERS
vs
S&P 500
Over the past 12 months, CERS has underperformed S&P 500, delivering a return of -19% compared to the S&P 500's 24% growth.
Stocks Performance
CERS vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance Gap
CERS vs S&P 500
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance By Year
CERS vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Competitors Performance
Cerus Corp vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
|
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Cerus Corp
Glance View
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The company is headquartered in Concord, California and currently employs 294 full-time employees. The company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, which is based on its technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives, such as plasma, platelets, red blood cells. Its product or product candidates under development includes INTERCEPT Blood System-Platelets, INTERCEPT Blood System-Plasma, INTERCEPT Blood System-Red Blood Cells and INTERCEPT Blood System-Cryoprecipitation. The INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products.